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large (≥3.0 mm) vessels in patients with Diabetes Mellitus?
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J.P. Metzger, C. Le Feuvre
CHU Pitié Salpêtrière, Département de Cardiologie Médicale, Paris,
France
Aim: Compare the effectiveness and safety of drug-eluting stent (DES) vs
bare metal stent (BMS) in diabetic patients treated by percutaneous coronary
intervention (PCI) for short lesions in large vessels (stent diameter ≥ 3.0 mm
AND stent length ≤ 18 mm). 
Methods: Consecutive patients treated with at least one large (≥ 3.0 mm)
and short (≤ 18 mm) stent were included over one year. Clinical and angio-
graphic data were prospectively entered into the "Middle-Care" database and
outcomes obtained at one year. We compare the occurrence of 1) cardiovas-
cular (CV) death, 2) MACCE (CV death, Myocardial Infarction (MI) and
stroke), 3) TVF (CV death, Target vessel MI, Target Vessel Revascularization
(TVR)), 4) TVR and 5) Target Lesion Revascularization (TLR) as 6) Stent
Thrombosis (ST) in the diabetic population according to the type of stent used
(DES vs BMS). 
Results: Three hundred ninety nine patients fulfilled inclusion criteria.
Among the 108 (27%) diabetic patients, 58% (n=63) underwent PCI with
BMS and 42% (n=45) with DES. Mean age was 65 ± 11 years, 82% (n=89)
were male, 32% (n=35) had acute coronary syndrome, 16% acute MI. Clinical
characteristics were well matched between the two groups, except for prior
PCI, acute MI and multivessel disease (19% vs 49%, 24% vs 4% and 49% vs
73%, for BMS vs DES respectively, p<0.05 for all). One year follow-up was
completed for 100% of the patients. Four (3.7%) patients died from CV cause,
8 (7.4%) had MACCE, 14 (13.0%) had TVF. Event rates in diabetics were
similar whatever the stent used (Figure). TVF rates were similar in diabetic
and non diabetic patients.
Conclusions: Diabetes does not increase the risk of TVF after PCI with
short stents in large vessels. At one year, no additional benefit was found with
the use of DES among diabetic patients in this setting. 
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Comparison between parameters known as to evaluate the platelet
turn-over.
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Introduction: Aspirin resistance has been widely studied, but few hypoth-
esis are proposed to explain such a mecanism. In our experience, more than a
third of patients treated for stable coronary heart disease by aspirin once a day
are not protected enough during the hole nycthemer. This could be due to an
increased platelet turn-over. The purpose of this study is to compare different
platelet turn-over markers.
Material and methods: In this prospective monocentric study, 50 patients
treated for stable coronary heart disease and taking only aspirin as an antipla-
telet treatment were included and compared to 55 controls from February to
August 2009. Parameters known as to quantify platelet turn-over were
measured, including mean platelet volume, reticulated platelets, platelet P
selectin and soluble P selectin, and seric thrombopoietin as well. Inflammation
markers were measured in both groups and these were usCRP, fibrinogen, VIII
factor and von Willebrand factor.
Results: Mean platelet volume, platelet P selectin, soluble P selectin and
seric thrombopoietin were found to be increased in patients more than in con-
trols (p<0,05). Inflammation parameters were noticed to be much higher in
patients. No statistical correlation was observed between these different tests,
neither with inflammation markers.
Conclusion: Platelet turn-over is increased at baseline in patients with
stable coronary heart disease. Inflammation was found to be much more
important among this cohort than in controls. Thus, the absence of statistical
correlation between these platelet turn-over markers suggests that some of
them better may quantify other parameters, which could be platelet activation.
More studies are required to establish whether these parameters could be
linked to aspirin resistance.
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Predictive factors of ST-Segment resolution after primary angioplasty
for acute myocardial infarction
Khaldoun Ben Hamda, Walid Jomaa, F Moatemeri, Sonia Hamdi, M
Amine Majdoub, Faouzi Maatouk
Centre Hospitalo-Universitaire, Cardiologie B, Monastir, Tunisie
In the setting of acute myocardial infarction (AMI), early resolution of ST-
segment elevation was a useful predictor of final infarct size, left ventricular
function and clinical outcome.
Impact of Age on Residual Platelet Activity
under Dual Antiplatelet therapy (ASA+Clopidogrel)
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